J. Barry Simon's most recent trade in ImmunityBio Inc was a trade of 75,000 Common Stock done at an average price of $12.0 . Disclosure was reported to the exchange on Feb. 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 24 Feb 2026 | 75,000 | 2,850,821 | - | 12.0 | 900,788 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 10.25 per share. | 20 Feb 2026 | 165,000 | 2,925,821 | - | 10.2 | 1,691,102 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2026 | 15,243 | 3,096,847 | - | 0 | Common Stock | |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2026 | 15,243 | 15,245 | - | - | Restricted Stock Units | |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 9.25 per share. | 20 Feb 2026 | 10,000 | 3,081,604 | - | 9.3 | 92,500 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.70 per share. | 20 Feb 2026 | 6,026 | 3,090,821 | - | 8.7 | 52,426 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 6.54 per share. | 20 Jan 2026 | 76,967 | 3,166,604 | - | 6.5 | 503,364 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 7.88 per share. | 20 Jan 2026 | 75,000 | 3,091,604 | - | 7.9 | 590,933 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 15,243 | 30,488 | - | - | Restricted Stock Units | |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 15,243 | 3,249,024 | - | 0 | Common Stock | |
| ImmunityBio Inc | Barry J. Simon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.42 per share. | 22 Feb 2025 | 5,453 | 3,243,571 | - | 3.4 | 18,649 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 22 Jan 2025 | 110,020 | 3,233,781 | - | 2.0 | 219,864 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2025 | 110,020 | 0 | - | - | Stock Option (right to buy) | |
| Viracta Therapeutics Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| ImmunityBio Inc | Barry Simon J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 159,146 | 159,146 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 45,731 | 45,731 | - | - | Restricted Stock Units | |
| ImmunityBio Inc | J. Barry Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 57,200 | 3,145,855 | - | 0 | Common Stock | |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 57,200 | 0 | - | - | Restricted Stock Units | |
| ImmunityBio Inc | J. Simon Barry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.36 per share. | 31 Jan 2024 | 22,094 | 3,123,761 | - | 3.4 | 74,236 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2023 | 114,399 | 114,399 | - | - | Restricted Stock Units | |
| Viracta Therapeutics Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Viracta Therapeutics Inc | Barry J. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| ImmunityBio Inc | Barry J. Simon | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 71,051 | 3,031,456 | - | 0 | Common Stock | |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 16.18 per share. | 21 May 2021 | 88,787 | 3,102,507 | - | 16.2 | 1,436,822 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 16.02 per share. | 21 May 2021 | 21,223 | 3,191,294 | - | 16.0 | 340,071 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 16.09 per share. | 21 May 2021 | 14,990 | 3,212,517 | - | 16.1 | 241,164 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.75 per share. | 05 May 2021 | 56,967 | 3,227,507 | - | 1.8 | 99,943 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 56,967 | 0 | - | - | Stock Option (right to buy) |